- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Mankind Pharma Limited — Updates, 28-11-2025: General Updates
28-11-2025 | 04:38 pm
28-11-2025 | 04:38 pm
Mankind Pharma received an independent ESG rating of 64.8 (Grade B) for FY24-25 from SES ESG Research. This assessment, based on public data, highlights the company's strong environmental, social, and governance profile.
No comments yet. Be the first to comment!